The use of disease-modifying agents in multiple sclerosis--by the Canadian Network of MS Clinics
Can J Neurol Sci. 2008 May;35(2):127-32.
[Article in
English,
French]
Collaborators
-
Canadian Network of MS Clinic:
J Antel, D Arnold, V Bhan, A Bar-Or, J Bakker, R Bell, C Boyle, D Brunet, F Costello, P Duquette, M Freedman, A Gomori, F Grand-Maison, T A Gray, W Hader, M Hohol, O Hrebicek, J Hooge, M Kremenchutzky, L Lee, R A Marrie, J Murray, M L Myles, L Metz, J Oger, D G Patry, A Prat, H Rabinovitch, C Short, P Smyth, A Traboulsee, G Vorobeychik
Affiliation
- 1 Department of Neurology, St. Michael's Hospital (POC), Toronto, ON, Canada.
No abstract available
MeSH terms
-
Canada
-
Computer Communication Networks / statistics & numerical data
-
Guidelines as Topic / standards*
-
Humans
-
Immunologic Factors / therapeutic use*
-
Immunosuppressive Agents / therapeutic use*
-
Multiple Sclerosis / drug therapy*
-
Multiple Sclerosis / epidemiology
Substances
-
Immunologic Factors
-
Immunosuppressive Agents